DICLOFENAC
Manner of administration:Application
Restriction
Indication: Solar (actinic) keratosis
Treatment phase: Management
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 3 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
| Solaraze 3% Gel | DPMQ: $63.35 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||